North American sales of RayStation continue to gain momentum

RayStation ® is gaining an ever-stronger foothold in the North American market. Several leading treatment centers selected RayStation, or extended the clinical footprint of existing systems, in the first quarter of 2017. 

Some of the most important of these facilities include:

  • Kennestone Hospital (a WellStar Health System facility) selected a full range of technologies, including Plan Explorer, an innovative tool to automatically prepare plans using several modalities to assess the best treatment approach.
  • Sharp Memorial Hospital (an affiliate within Sharp HealthCare) selected a broad range of technologies.
  • The Maryland Proton Treatment Center, in collaboration with the University of Maryland, extended its installation of RayStation, including additional clinical licenses for both photon and proton planning. RayStation will be used for pencil beam/IMPT planning on the Varian ProBeam system at MPTC.

    Katja Langen, PhD, Associate Chief of Medical Physics at MPTC, says: “We aim to provide world-class proton therapy to achieve the best possible outcomes for patients. To be at the cutting edge, we need access to the most advanced and innovative treatment planning technologies. We are excited to add RayStation to our treatment planning portfolio.”

Marc Mlyn, President of RaySearch Americas, says: “RayStation is increasingly acknowledged as the most innovative and comprehensive treatment planning system on one platform, and we are excited about the continuing upward sales trend in North America. It is gratifying that so many leading centers are turning to RayStation for their treatment planning needs.”

About RayStation
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare®*, which comprises a new product area for RaySearch, and which will be launched in 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.

* Subject to regulatory clearance in some markets

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com

About Us

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading medical technology companies such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched via partners and RaySearch’s software is used by over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the company is listed in the Small Cap segment on Nasdaq Stockholm.

Subscribe

Media

Media

Documents & Links